期刊文献+

2型糖尿病各期肾病病人载脂蛋白等变化分析 被引量:2

下载PDF
导出
摘要 选择健康人40例及我院住院2型糖尿病病人110人,根据24小时尿白蛋白定量分为糖尿病无肾病组(A组)、早期肾病组(B组)及临床期肾病组(C组),全部病人测定血甘油三脂(TG)、胆固醇(TC)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、载脂蛋白A1(ApoA1)、载脂蛋白B(ApoB),将各组指标分析比较。结果:B组、C组病人血TG较A组病人升高更明显,TC较正常组升高(P<0.05),A组、B组、C组HDL-C均有下降,而B组、C组下降更有意义(P<0.01).B组、C组血LDL-C较A组升高,有统计学意义,B组、C组血ApoA1下降,ApoB升高,ApoB/ApoA1升高。结论:糖尿病肾病病人血脂及载脂蛋白显著异常,对糖尿病合并早期及临床期肾病病人应严格控制血脂水平。
作者 靖涛 许枚
出处 《实用糖尿病杂志》 2006年第2期22-23,共2页 Journal of Practical Diabetology
  • 相关文献

参考文献6

  • 1Niskanenl. Hperglycemia and compositional lipoprotein abnormality as predictors of cardiovascular mortality in type 2 diabetes. Diabetes Care 1998;21:1861.
  • 2Kuusisto J. Noninsulin dependent diabetes and its metabolic control are important predictors of stroke in elderly. Subjects Stroke1994;45(6) : 1157.
  • 3CJ Packard. Apolipoproteins;the new prognostic indicator? European Heart Journal Supplements 2003 ;5 :D9 - D16.
  • 4C Meismger. H. Prognostic value of apolipoprotein B and A1 in the prediction of myocardialinfarction in middle - aged men and women. Eur heart J 2005;26(3) :271.
  • 5Hammad SM, et al. Nephropathy in a hypercholesterolemic mouse model with streptozotocin - induced diabetes. Kidney Blood Press Res 2003 ;26(5 - 6) :351.
  • 6Nish Chaturvedi, Differing associations of lipid and lipoprotein disturbances with the maerovascular and mierovascular complications of type 1 diabetes. Diabetes Care 2001 ; 24 ; 2071.

同被引文献17

  • 1王艳林,刘孝全.载脂蛋白B研究进展[J].实用医学进修杂志,1993,21(4):60-64. 被引量:1
  • 2荆朝辉,张晓膺,NING Xu,罗光华,董选.2型糖尿病患者中载脂蛋白M与脂蛋白a、载脂蛋白AI的关系研究[J].现代医学,2006,34(2):96-100. 被引量:11
  • 3张森,李辉.载脂蛋白B研究进展[J].国际遗传学杂志,2006,29(5):364-367. 被引量:13
  • 4WANG Y, NG M C, LEE S C, et al. Phenotypic heterogeneity and associations of two aldose reductase gene polymorphisms with nephropathy and retinopathy in type 2 diabetes [ J ]. Diabetes Care, 2003, 26(8): 2410-2415.
  • 5VAZIRI N D, NORRIS K. Lipid disorders and their relevance to outcomes in chronic kidney disease [ J ]. Blood Purif, 2011, 31 (1/3) : 189 -196.
  • 6DESROCHES S, RUEL I L, DESHAIES Y, et al. Kinetics of plasma apolipoprotein C - Ⅲ as a determinant of diet - induced changes in plasma triglyceride levels [ J ]. Eur Clin Nutr, 2008, 62(1): 10-17.
  • 7HAFFNER S M, D'AGOSTINO R Jr, MYKKANEN L, et al. In- sulin sensitivity in subjects with type 2 diabetes. Relationship to cardiovascular risk factors: the insulin resistance atheroselerosis study[J]. Diabetes Care, 1999, 22(4) : 562 -568.
  • 8CHAN D C, WATIS G F, BARRETY P H, et al. Markers of tri- glyeeride- rich lipoprotein remnantmetabolism in visceral obesity [J]. Clin Chem, 2002, 48(2) : 278 -283.
  • 9KAWAKAMI A, AIKAWA M, LIBBY P, et al. Apolipoprotein C Ⅲ in apolipoprotein B lipoproteins enhances the adhesion of hu- manmonocytic cells to endothelial cells [ J ]. Circulation, 2006, 113(5) : 691 -700.
  • 10HIRANO T. Lipoprotein abnormalities in diabetic nephropathy [J]. Kidney Int Suppl, 1999, 71:S22 -S24.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部